MAIA Biotechnology
thio trial patients dosed to date | MAIA Biotechnology
Company
Deck Type
Sector
Industry
Deck date
October 2023
Slide
13 of 39
Similar slides by MAIA Biotechnology
See diffirences between slides (animation)
Investor Presentation
January 2024
thio trial patients dosed to date | MAIA Biotechnology
Investor Presentation
November 2023
thio trial patients dosed to date | MAIA Biotechnology
Investor Presentation
July 2023
thio trial patients dosed to date | MAIA Biotechnology
Related slides by other companies
Avenue Therapeutics
IPO
October 2022
safety and efficacy has been demonstrated in two phase trials in over patients | Avenue Therapeutics
OKYO Pharma
Results
June 2023
phase trial design rota | OKYO Pharma
MindMed
Investor Presentation
December 2024
phase trial schematic schematic week a dose optimization study of | MindMed
argenx SE
Investor Presentation
November 2023
myositis trial | argenx SE
Other recent decks by MAIA Biotechnology
See all presentations (4 decks)
Investor Presentation
January 2024
Investor Presentation
November 2023
Investor Presentation
July 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights